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Abstract 
 
Background: To evaluate the frequency and time of 
presentation of benign and malignant breast lumps among 
pregnant females.  
Methods: In this descriptive study all pregnant females 
with a complaint of lump in breast were included . Triple 
assessment was done for each patient (examination of 
lump, ultrasound for patients under 40 years, 
mammography for those above 40 years and fine needle 
aspiration cytology). 
Results:  Out of 78  pregnant females, with complaints 
of breast lump, 47 (60.25%) were found to have breast 
lumps  and 31 (38.75%) had pregnancy induced changes. 
Majority of the patients (85.1%) had benign breast disease. 
Out of seven patients (14.9%) with malignant breast 
disease, three (4.3%)  were primigravidas as compared to 
patients with benign breast disorders where  only 6 out of 
40 cases (15%) were primigravidas. Mean age of patients 
with benign breast disease was 27 years (range 15-40 years) 
and mean age of those  with malignant lumps was 35 
years( range 29-43 years). Approximately 51% of all lumps 
presented during first and second trimester and rest 
during  third trimester .  On histopathological examination 
all malignant lumps proved to be intraductal carcinomas.  
Conclusion:  The incidence  of breast lumps during 
pregnancy is slightly higher (14.9%) than in non-pregnant 
females although majority of breast lumps during 
pregnancy are   benign. 
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Introduction 
The reported incidence of pregnancy 
associated breast cancer ranges from 0.7-3.8% of all 
diagnosed breast cancers.  Majority of the breast lumps 
detected during pregnancy are not cancerous. 
Pregnancy associated breast cancer is defined as breast 
cancer diagnosed during pregnancy or within one year 
of delivery. Pregnancy associated breast cancer poses a 
threat not only for the patient but also to the infant if 
timely diagnosis and treatment are not carried out. 1 
Breast cancer is the second most common 
cancer in women of child bearing age. Obstetricians all 
over the world are witnessing an increasing number of 
women who are pregnant and suffering from breast 
cancer, as an increasing number of women are 
delaying pregnancy. Breast cancer is difficult to 
diagnose during advanced pregnancy due to 
pregnancy induced changes in the breast tissue. But, 
since breast cancer and pregnancy both affect each 
other in several ways, it is important to have an early 
breast examination and screening in the obstetrician’s 
clinic, to avoid the risk of late diagnosis of breast 
cancer during pregnancy and to alleviate undue 
anxiety in patients suffering from non malignant 
breast disorders. 2 
 
Methods 
All pregnant females with complaints of breast 
lump, who came to the surgical out patient 
department at Pakistan Institute of Medical Sciences. 
from June 2005 to October 2006, were included. Triple 
assessment was done for each patient (examination of 
lump, ultrasound for patients under 40 years or 
mammography for those above 40 years and FNAC). 3 
After diagnosis, benign lumps were treated either 
conservatively or by excision biopsy and malignant 
lumps were treated according to standard guidelines 
for breast cancer management viz. modified radical 
mastectomy either during pregnancy or two weeks 
after delivery. This was followed by standard 
chemotherapy during or after pregnancy, based on 
disease stage. For all patients radiotherapy was 
postponed until after delivery. 
 
Results 
A total of 78 patients were referred with 
complaints of breast lump out of these 47 (60.25%) 
were found to have lump and 31 (38.75%) were found 
to have pregnancy induced changes in breast. 
Minimum age of these patients was 15 years and  
maximum was 43 years (Table 1). On final diagnosis 20 
patients (42.6%) had fibroadenoma and 7 patients  
(14.9%) were diagnosed as having breast carcinoma, 
all being intraductal(Table 2). Thirty eight (80.9%) 
patients had  lumps less than 5 cm in size. Age specific 
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diagnoses showed that majority of the young patients 
suffered from benign breast disease (Table 3). Among 
the benign breast disease group only 6 out of 40 (15%) 
were primigravidas where as 3 out of 7 (42.9%) breast 
cancer patients aged 36,37 and 39 were primigravidas. 
Eighty percent patients with benign breast disorders 
presented within five months of noticing the lump as 
compared to those with malignant lumps, all of who 
presented five months or more after noticing the 
lump(Table 4).  In this study 68% patients presented 
during second and third trimester(Table 5). The mean 
stage of presentation for benign lumps was at 15 
weeks of gestation whereas the mean stage of 
presentation of breast cancer cases was at 29.6 weeks.  
Patients with mastitis, fat necrosis, cysts and 
hematoma were treated conservatively. Breast 
adenomas,  cystosarcomas, and accessory breasts were 
all treated by excision biopsy and all patients with 
carcinoma underwent modified radical mastectomy., 
Five patients with malignant lumps were operated 
during pregnancy and two patients who presented 
during last month of gestation were operated two 
weeks after delivery.  
 
Table 1: Distribution of cases according to age  
Age groups Benign  
No(%) 
Malignant 
No(%)  
15-20 years 10(100) No case 
21-25 years 8(100) No case 
26-30 years 10(83.3) 2 (16.7) 
31-35 years 6(85.7) 1(14.3) 
Above 35 years 7(63.3) 4(36.7) 
 
Table 2:Pregnancy associated breast diseases 
 Diagnosis No(%) 
Fibroadenoma 20( 42.6 ) 
Acute mastitis 5(10.6 ) 
Chronic mastitis* 2(  4.3 ) 
Single cyst 3(6.4 ) 
Accessory breast 4(8.5) 
Hematoma 1 ( 2.1) 
Cystosarcoma phyllodes 1 ( 2.1) 
Carcinoma 7(14.9 ) 
Infected sebaceous cyst 2(4.3) 
Giant fibroadenoma 1(2.1 ) 
Fat necrosis 1( 2.1) 
 Total 47(100.0 ) 
*Both were tuberculous and treated by anti tuberculous drugs 
 
Table 3: Mean Presentation Ages of Patients 
Diagnosis No. of cases 
Minimum age 
at 
presentation 
(yrs) 
Maximum 
age at 
presentation 
( yrs) 
Mean age 
(yrs) 
Benign 
lumps 
40 15 37 22.3 
Malignant 
lumps 
7 29 47 35 
 
Table. 4. Duration between first doubt about the 
lump and presentation at hospital 
Duration since noticing 
the lump 
Benign 
disorders 
No(%) 
Malignant 
disorders 
No(%) 
One month or less 6 (12.8%) 0 
Two months 9 (19.1%) 0 
Three months 6 (12.8%) 0 
Four months 6 (12.8%) 0 
Five months 5 (10.6%) 1 (2.1%) 
Six months  2 (4.2%) 3 (6.4%) 
More than six months 6 (12.8%) 3 (6.4%) 
Total 40 (85.1%) 7 (14.9%) 
 
Table 5: Presentation of breast lumps according to 
trimester  
Trimester No(%) 
First (up to 13 weeks) 15(31.9) 
Second (14 to 26 weeks) 9(19.2) 
Third (27 to 40 weeks) 23(48.9) 
 
Discussion 
Breasts undergo changes during pregnancy 
making it difficult to diagnose any concomitant 
pathology during late pregnancy when breasts are 
large and heavy due to proliferation of glandular 
tissue and vascular engorgement. Diagnosis of breast 
cancer during pregnancy can be devastating and 
formidable to any patient who is happily dreaming 
about motherhood. Most breast tumors during or 
shortly after pregnancy first appear as a painless 
breast lump/s. It is difficult to palpate and assess 
small lumps due to hypercellularity and 
hypervascularity of breast tissue resulting in doubt 
about the lump, which leads to a late presentation.4,5 
Early menarche, late menopause and late age 
at first pregnancy are associated with an increased risk 
due to higher exposure to estrogen caused by 
increased number of cycles. 6 Parity reduces the risk of 
breast cancer, and nulliparity and late age at first 
pregnancy are associated with an increased risk. 7 
Studies show that in women aged 50–79 years who 
nursed their children, there is a reduction in the risk of 
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carcinoma breast.6,7 
     Patients remain in doubt about the presence of 
lump amidst pregnancy induced changes, for a 
variable period of time and this causes a delay in 
attending the clinic. In this study only 12.8% patients 
presented within first month of doubting the presence 
of a lump.Pregnancy-associated breast cancer cases  
significantly have an advanced stage, larger primary 
tumor, hormone receptor negativity, and mastectomy 
as a component of their treatment. 8 
      For the diagnosis ultrasound is an important 
adjunct to mammography (no radiation hazard due to 
internal scatter). It differentiates between solid and 
cystic masses and gives some guidance to the nature of 
the solid mass by outlining the margins of the lump 
(smooth in benign and irregular in malignant). Since 
mother’s life has preference over infant’s, 
mammography with a pelvic shield is justifiable in 
cases where diagnosis is in doubt in spite of initial non 
hazardous methods. Fine needle aspiration cytology is 
a good initial diagnostic tool but the chances of false 
positive are increased due to higher number of 
multiplying cells. Biopsy, trucut or open is 
recommended due to its higher sensitivity but it can 
lead to milk fistula. 9 
     Treatment should conform as closely as possible to 
standardized protocols for patients without 
concomitant pregnancy.For cancers discovered during 
first half the standard treatment option is surgery 
either lumpectomy or modified radical mastectomy, 
depending upon the stage of the disease. 10 This has to 
be followed by adjuvant chemotherapy late in second 
trimester. Chemotherapeutic agents used are 
Adriamycin, Cyclophosphamide, Doxorubicin and 
Taxanes. During the second and third trimesters 
chemotherapy does not induce  congenital 
malformations in the infant. Post surgical Radiation 
exposure during the first trimester (>0.1 Gy) may lead 
to congenital malformations, mental retardation, and 
increased relative risk of carcinogenesis. Radiation is 
therefore recommended only after delivery. For 
cancers diagnosed during second half of pregnancy 
surgical options remain the same. For stage I and II 
disease, chemotherapy can be delayed until after 
delivery. Chemotherapy should stop six weeks prior 
to delivery since it causes bone marrow depression 
with low white blood cells counts in the infant. 11,12 
For late stage breast cancer (Stage III and IV ) 
most studies show that a 5-year survival rate in 
pregnant patients is only 10 % if chemo and 
radiotherapy are delayed. Continuation of the 
pregnancy should therefore be discussed with the 
patient and her family if she presents during first 
trimester with a late disease. There is no effect of 
therapeutic abortion on prognosis otherwise. 13  
Patient who suffered breast cancer during 
pregnancy should be advised to practice contraception 
for two years as this is the period for maximum 
recurrence. If a patient has axillary node involvement, 
the recommended period to defer pregnancy should 
be extended to five years. 14 
 
Conclusion  
Pregnancy associated changes in breast can lead to one 
overlooking the breast lesion  
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